Genetics of essential tremor: From phenotype to genes, insights from both human and mouse studies

Progress in Neurobiology

Volumn 119-120, Issue , 2014, Pages 1-19

  Schmouth, Jean François ^a,b   Dion, Patrick A ^a,b   Rouleau, Guy A ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Brain; Essential tremor; Genetics; Human population; Mouse models; Pathophysiology

Indexed keywords

DOPAMINE RECEPTOR D3 GENE; ESSENTIAL TREMOR; EVIDENCE BASED PRACTICE; FUSED IN SARCOMA GENE; GENE; GENETIC ASSOCIATION; HEMATOPOIETIC SPECIFIC PROTEIN 1 BINDING PROTEIN 3 GENE; HUMAN; LEUCINE RICH REPEAT AND IG DOMAIN CONTAINING 1 GENE; MEDICAL GENETICS; MOLECULAR PATHOLOGY; MOUSE; NEUROIMAGING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTE CARRIER FAMILY 1 GLIAL AFFINITY GLUTAMATE TRANSPORTER MEMBER 2 GENE; ANIMAL; BRAIN; GENETICS; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BRAIN; ESSENTIAL TREMOR; HUMANS; MICE; PHENOTYPE;

EID: 84905400654     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2014.05.001     Document Type: Review

References (281)

1. Abdul H.M., Sama M.A., Furman J.L., Mathis D.M., Beckett T.L., Weidner A.M., Patel E.S., Baig I., Murphy M.P., LeVine H., Kraner S.D., Norris C.M. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J. Neurosci. 2009, 29:12957-12969.
2. Agundez J.A., Jimenez-Jimenez F.J., Alonso-Navarro H., Garcia-Martin E. FUS: a putative biomarker for essential tremor raised by whole-exome sequencing analyses. Pharmacogenomics 2013, 14:1680-1681.
3. Agundez J.A., Jimenez-Jimenez F.J., Alonso-Navarro H., Garcia-Martin E. Genome-wide association study raised biomarker SLC1A2 rs3794087 and essential tremor: is it too early to say?. Pharmacogenomics 2013, 14:1679-1680.
4. Axelrad J.E., Louis E.D., Honig L.S., Flores I., Ross G.W., Pahwa R., Lyons K.E., Faust P.L., Vonsattel J.P. Reduced Purkinje cell number in essential tremor: a postmortem study. Arch. Neurol. 2008, 65:101-107.
5. Ayala Y.M., Zago P., D'Ambrogio A., Xu Y.F., Petrucelli L., Buratti E., Baralle F.E. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 2008, 121:3778-3785.
6. Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote D-loop formation. J. Biol. Chem. 1999, 274:34337-34342.
7. Bain P., Brin M., Deuschl G., Elble R., Jankovic J., Findley L., Koller W.C., Pahwa R. Criteria for the diagnosis of essential tremor. Neurology 2000, 54:S7.
8. Bain P.G., Findley L.J., Thompson P.D., Gresty M.A., Rothwell J.C., Harding A.E., Marsden C.D. A study of hereditary essential tremor. Brain 1994, 117(Pt 4):805-824.
9. Bares M., Husarova I., Lungu O.V. Essential tremor, the cerebellum, and motor timing: towards integrating them into one complex entity. Tremor Other Hyperkinet. Mov. (N Y) 2012, 2.
10. Batini C., Buisseret-Delmas C., Conrath-Verrier M. Olivo-cerebellar activity during harmaline-induced tremor. A 2-[14C]deoxyglucose study. Neurosci. Lett. 1979, 12:241-246.
11. Batini C., Buisseret-Delmas C., Conrath-Verrier M. Harmaline-induced tremor I. Regional metabolic activity as revealed by [14C]2-deoxyglucose in cat. Exp. Brain Res. 1981, 42:371-382.
12. Beecham A.H., Patsopoulos N.A., Xifara D.K., Davis M.F., Kemppinen A., Cotsapas C., Shah T.S., Spencer C., Booth D., Goris A., Oturai A., Saarela J., Fontaine B., Hemmer B., Martin C., Zipp F., D'Alfonso S., Martinelli-Boneschi F., Taylor B., Harbo H.F., Kockum I., Hillert J., Olsson T., Ban M., Oksenberg J.R., Hintzen R., Barcellos L.F., Agliardi C., Alfredsson L., Alizadeh M., Anderson C., Andrews R., Sondergaard H.B., Baker A., Band G., Baranzini S.E., Barizzone N., Barrett J., Bellenguez C., Bergamaschi L., Bernardinelli L., Berthele A., Biberacher V., Binder T.M., Blackburn H., Bomfim I.L., Brambilla P., Broadley S., Brochet B., Brundin L., Buck D., Butzkueven H., Caillier S.J., Camu W., Carpentier W., Cavalla P., Celius E.G., Coman I., Comi G., Corrado L., Cosemans L., Cournu-Rebeix I., Cree B.A., Cusi D., Damotte V., Defer G., Delgado S.R., Deloukas P., di Sapio A., Dilthey A.T., Donnelly P., Dubois B., Duddy M., Edkins S., Elovaara I., Esposito F., Evangelou N., Fiddes B., Field J., Franke A., Freeman C., Frohlich I.Y., Galimberti D., Gieger C., Gourraud P.A., Graetz C., Graham A., Grummel V., Guaschino C., Hadjixenofontos A., Hakonarson H., Halfpenny C., Hall G., Hall P., Hamsten A., Harley J., Harrower T., Hawkins C., Hellenthal G., Hillier C., Hobart J., Hoshi M., Hunt S.E., Jagodic M., Jelcic I., Jochim A., Kendall B., Kermode A., Kilpatrick T., Koivisto K., Konidari I., Korn T., Kronsbein H., Langford C., Larsson M., Lathrop M., Lebrun-Frenay C., Lechner-Scott J., Lee M.H., Leone M.A., Leppa V., Liberatore G., Lie B.A., Lill C.M., Linden M., Link J., Luessi F., Lycke J., Macciardi F., Mannisto S., Manrique C.P., Martin R., Martinelli V., Mason D., Mazibrada G., McCabe C., Mero I.L., Mescheriakova J., Moutsianas L., Myhr K.M., Nagels G., Nicholas R., Nilsson P., Piehl F., Pirinen M., Price S.E., Quach H., Reunanen M., Robberecht W., Robertson N.P., Rodegher M., Rog D., Salvetti M., Schnetz-Boutaud N.C., Sellebjerg F., Selter R.C., Schaefer C., Shaunak S., Shen L., Shields S., Siffrin V., Slee M., Sorensen P.S., Sorosina M., Sospedra M., Spurkland A., Strange A., Sundqvist E., Thijs V., Thorpe J., Ticca A., Tienari P., van Duijn C., Visser E.M., Vucic S., Westerlind H., Wiley J.S., Wilkins A., Wilson J.F., Winkelmann J., Zajicek J., Zindler E., Haines J.L., Pericak-Vance M.A., Ivinson A.J., Stewart G., Hafler D., Hauser S.L., Compston A., McVean G., De Jager P., Sawcer S.J., McCauley J.L. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat. Genet. 2013, 45:1353-1360.
13. Belzil V.V., Daoud H., St-Onge J., Desjarlais A., Bouchard J.P., Dupre N., Lacomblez L., Salachas F., Pradat P.F., Meininger V., Camu W., Dion P.A., Rouleau G.A. Identification of novel FUS mutations in sporadic cases of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011, 12:113-117.
14. Beom S., Cheong D., Torres G., Caron M.G., Kim K.M. Comparative studies of molecular mechanisms of dopamine D2 and D3 receptors for the activation of extracellular signal-regulated kinase. J. Biol. Chem. 2004, 279:28304-28314.
15. Berger U.V., Hediger M.A. Comparative analysis of glutamate transporter expression in rat brain using differential double in situ hybridization. Anat. Embryol. (Berl.) 1998, 198:13-30.
16. Bertrand P., Akhmedov A.T., Delacote F., Durrbach A., Lopez B.S. Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 1999, 18:4515-4521.
17. Bezard E., Ferry S., Mach U., Stark H., Leriche L., Boraud T., Gross C., Sokoloff P. Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat. Med. 2003, 9:762-767.
18. Blair I.P., Williams K.L., Warraich S.T., Durnall J.C., Thoeng A.D., Manavis J., Blumbergs P.C., Vucic S., Kiernan M.C., Nicholson G.A. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis. J. Neurol. Neurosurg. Psychiatry 2010, 81:639-645.
19. Blair M.A., Ma S., Phibbs F., Fang J.Y., Cooper M.K., Davis T.L., Hedera P. Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism Relat. Disord. 2008, 14:471-475.
20. Boecker H., Weindl A., Brooks D.J., Ceballos-Baumann A.O., Liedtke C., Miederer M., Sprenger T., Wagner K.J., Miederer I. GABAergic dysfunction in essential tremor: an 11C-flumazenil PET study. J. Nucl. Med. 2010, 51:1030-1035.
21. Bordet R., Ridray S., Carboni S., Diaz J., Sokoloff P., Schwartz J.C. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:3363-3367.
22. Bourassa C.V., Riviere J.B., Dion P.A., Bernard G., Diab S., Panisset M., Chouinard S., Dupre N., Fournier H., Raelson J., Belouchi M., Rouleau G.A. LINGO1 variants in the French-Canadian population. PLoS ONE 2011, 6:e16254.
23. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 1991, 564:203-219.
24. Bramham C.R., Wells D.G. Dendritic mRNA: transport, translation and function. Nat. Rev. Neurosci. 2007, 8:776-789.
25. Bucher S.F., Seelos K.C., Dodel R.C., Reiser M., Oertel W.H. Activation mapping in essential tremor with functional magnetic resonance imaging. Ann. Neurol. 1997, 41:32-40.
26. Bush W.S., Sawcer S.J., de Jager P.L., Oksenberg J.R., McCauley J.L., Pericak-Vance M.A., Haines J.L. Evidence for polygenic susceptibility to multiple sclerosis - the shape of things to come. Am. J. Hum. Genet. 2010, 86:621-625.
27. Carim-Todd L., Escarceller M., Estivill X., Sumoy L. LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. Eur. J. Neurosci. 2003, 18:3167-3182.
28. Chan J.R., Watkins T.A., Cosgaya J.M., Zhang C., Chen L., Reichardt L.F., Shooter E.M., Barres B.A. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 2004, 43:183-191.
29. Chang K.Y., Park Y.G., Park H.Y., Homanics G.E., Kim J., Kim D. Lack of CaV3.1 channels causes severe motor coordination defects and an age-dependent cerebellar atrophy in a genetic model of essential tremor. Biochem. Biophys. Res. Commun. 2011, 410:19-23.
30. Chansky H.A., Hu M., Hickstein D.D., Yang L. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 2001, 61:3586-3590.
31. Chaudhry F.A., Lehre K.P., van Lookeren Campagne M., Ottersen O.P., Danbolt N.C., Storm-Mathisen J. Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 1995, 15:711-720.
32. Chen J.J., Swope D.M. Essential tremor: diagnosis and treatment. Pharmacotherapy 2003, 23:1105-1122.
33. Clark L.N., Park N., Kisselev S., Rios E., Lee J.H., Louis E.D. Replication of the LINGO1 gene association with essential tremor in a North American population. Eur. J. Hum. Genet. 2010, 18:838-843.
34. Crews L., Spencer B., Desplats P., Patrick C., Paulino A., Rockenstein E., Hansen L., Adame A., Galasko D., Masliah E. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE 2010, 5:e9313.
35. Damotte V., Guillot-Noel L., Patsopoulos N.A., Madireddy L., El Behi M., Ban M., Baranzini S., Barcellos L., Beecham G., Beecham A., Bernardinelli L., Booth D., Bos S., Buck D., Bush W., Comabella M., Compston A., Cotsapas C., Cournu-Rebeix I., Cree B., D'Alfonso S., Daly M., Davis M., de Bakker P., De Jager P.L., Dubois B., Esposito F., Fontaine B., Goris A., Gourraud P.A., Green T., Gulowsen Celius E., Hadjixenofontos A., Hafler D., Haines J., Flinstad H.F., Hauser S., Hawkins C., Hemmer B., Hillert J., Hintzen R., Horakova D., Ivinson A.J., Kemppinen A., Kira J.I., Kockum I., Lincoln R., Martin R., Martinelli Boneschi F., McCauley J.L., Mero I.L., Oksenberg J., Olsson T., Oturai A., Palotie A., Patsopoulos N., Pericak-Vance M., Rioux J., Saarela J., Sawcer S., Schnetz-Boutaud N., Sellebjerg F., Soendergaard H., Soelberg Sorensen P., Spurkland A., Stankovich J., Stewart G., Taylor B., Ticca A., West S., Zipp F., Donnelly P., Barroso I., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A., Jankowski J., Markus H.S., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Trembath R.C., Viswanathan A.C., Wood N.W., Spencer C.C., Band G., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Pearson R., Strange A., Su Z., Vukcevic D., Langford C., Hunt S.E., Edkins S., Gwilliam R., Blackburn H., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Potter S.C., Ravindrarajah R., Ricketts M., Waller M.J., Weston P., Widaa S., Whittaker P., Deloukas P., Dilthey A., Leslie S., Moutsianas L., Perez M.L., McVean G., McCarthy M.I., Baranzini S.E. A gene pathway analysis highlights the role of cellular adhesion molecules in multiple sclerosis susceptibility. Genes Immun. 2014, 15:126-132.
36. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 2001, 65:1-105.
37. Daniels C., Peller M., Wolff S., Alfke K., Witt K., Gaser C., Jansen O., Siebner H.R., Deuschl G. Voxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremor. Neurology 2006, 67:1452-1456.
38. de Lau L.M., Breteler M.M. Epidemiology of Parkinson's disease. Lancet Neurol. 2006, 5:525-535.
39. de Leon J., Susce M.T., Pan R.M., Koch W.H., Wedlund P.J. Polymorphic variations in GSTM1, GSTT1, PgP, CYP2D6. CYP3A5, and dopamine D2 and D3 receptors and their association with tardive dyskinesia in severe mental illness. J. Clin. Psychopharmacol. 2005, 25:448-456.
40. De Montigny C., Lamarre Y. Effects produced by local applications of harmaline in the inferior olive. Can. J. Physiol. Pharmacol. 1975, 53:845-849.
41. Deng H., Gu S., Jankovic J. LINGO1 variants in essential tremor and Parkinson's disease. Acta Neurol. Scand. 2012, 125:1-7.
42. Deng H., Le W., Jankovic J. Genetics of essential tremor. Brain 2007, 130:1456-1464.
43. Deng H., Le W.D., Guo Y., Huang M.S., Xie W.J., Jankovic J. Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 2005, 65:651-652.
44. Deng H., Le W.D., Hunter C.B., Mejia N., Xie W.J., Jankovic J. A family with Parkinson disease, essential tremor, bell palsy, and Parkin mutations. Arch. Neurol. 2007, 64:421-424.
45. Deng H., Xie W.J., Le W.D., Huang M.S., Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci. Lett. 2006, 401:16-19.
46. Deuschl G., Bain P., Brin M. Consensus statement of the Movement Disorder Society on Tremor Ad Hoc Scientific Committee. Mov. Disord. 1998, 13(Suppl. 3):2-23.
47. Deuschl G., Elble R. Essential tremor - neurodegenerative or nondegenerative disease towards a working definition of ET. Mov. Disord. 2009, 24:2033-2041.
48. Diaz J., Levesque D., Lammers C.H., Griffon N., Martres M.P., Schwartz J.C., Sokoloff P. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 1995, 65:731-745.
49. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., Tanzer A., Lagarde J., Lin W., Schlesinger F., Xue C., Marinov G.K., Khatun J., Williams B.A., Zaleski C., Rozowsky J., Roder M., Kokocinski F., Abdelhamid R.F., Alioto T., Antoshechkin I., Baer M.T., Bar N.S., Batut P., Bell K., Bell I., Chakrabortty S., Chen X., Chrast J., Curado J., Derrien T., Drenkow J., Dumais E., Dumais J., Duttagupta R., Falconnet E., Fastuca M., Fejes-Toth K., Ferreira P., Foissac S., Fullwood M.J., Gao H., Gonzalez D., Gordon A., Gunawardena H., Howald C., Jha S., Johnson R., Kapranov P., King B., Kingswood C., Luo O.J., Park E., Persaud K., Preall J.B., Ribeca P., Risk B., Robyr D., Sammeth M., Schaffer L., See L.H., Shahab A., Skancke J., Suzuki A.M., Takahashi H., Tilgner H., Trout D., Walters N., Wang H., Wrobel J., Yu Y., Ruan X., Hayashizaki Y., Harrow J., Gerstein M., Hubbard T., Reymond A., Antonarakis S.E., Hannon G., Giddings M.C., Ruan Y., Wold B., Carninci P., Guigo R., Gingeras T.R. Landscape of transcription in human cells. Nature 2012, 489:101-108.
50. Domeniconi M., Filbin M.T. Overcoming inhibitors in myelin to promote axonal regeneration. J. Neurol. Sci. 2005, 233:43-47.
51. Du W., Aloyo V.J., Harvey J.A. Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Brain Res. 1997, 770:26-29.
52. Duval C., Sadikot A.F., Panisset M. Bradykinesia in patients with essential tremor. Brain Res. 2006, 1115:213-216.
53. Elble R.J. Diagnostic criteria for essential tremor and differential diagnosis. Neurology 2000, 54:S2-S6.
54. Elble R.J. Report from a U.S. conference on essential tremor. Mov. Disord. 2006, 21:2052-2061.
55. Elble R.J., Higgins C., Hughes L. Essential tremor entrains rapid voluntary movements. Exp. Neurol. 1994, 126:138-143.
56. Farkas Z., Szirmai I., Kamondi A. Impaired rhythm generation in essential tremor. Mov. Disord. 2006, 21:1196-1199.
57. French L., Pavlidis P. Relationships between gene expression and brain wiring in the adult rodent brain. PLoS Comput. Biol. 2011, 7:e1001049.
58. Fu Q.L., Hu B., Wu W., Pepinsky R.B., Mi S., So K.F. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection. Invest. Ophthalmol. Vis. Sci. 2008, 49:975-985.
59. Fujii R., Grossenbacher-Zinchuk O., Jamari I., Wang Y., Zinchuk V., Takumi T. TLS-GFP cannot rescue mRNP formation near spines and spine phenotype in TLS-KO. Neuroreport 2009, 20:57-61.
60. Fujii R., Okabe S., Urushido T., Inoue K., Yoshimura A., Tachibana T., Nishikawa T., Hicks G.G., Takumi T. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr. Biol. 2005, 15:587-593.
61. Fujii R., Takumi T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J. Cell Sci. 2005, 118:5755-5765.
62. Garcia-Martin E., Lorenzo-Betancor O., Martinez C., Pastor P., Benito-Leon J., Millan-Pascual J., Calleja P., Diaz-Sanchez M., Pisa D., Turpin-Fenoll L., Alonso-Navarro H., Ayuso-Peralta L., Torrecillas D., Lorenzo E., Plaza-Nieto J.F., Agundez J.A., Jimenez-Jimenez F.J. LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis. BMC Neurol. 2013, 13:34.
63. Garcia-Martin E., Martinez C., Alonso-Navarro H., Benito-Leon J., Lorenzo-Betancor O., Pastor P., Ortega-Cubero S., Lopez-Alburquerque T., Agundez J.A., Jimenez-Jimenez F.J. No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population. Pharmacogenet. Genomics 2013, 23:587-590.
64. Garcia-Martin E., Martinez C., Alonso-Navarro H., Benito-Leon J., Lorenzo-Betancor O., Pastor P., Puertas I., Rubio L., Lopez-Alburquerque T., Agundez J.A., Jimenez-Jimenez F.J. Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. J. Neurol. 2011, 258:203-211.
65. Garcia-Martin E., Martinez C., Alonso-Navarro H., Benito-Leon J., Lorenzo-Betancor O., Pastor P., Puertas I., Rubio L., Lopez-Alburquerque T., Agundez J.A., Jimenez-Jimenez F.J. Gamma-aminobutyric acid GABRA4. GABRE, and GABRQ receptor polymorphisms and risk for essential tremor. Pharmacogenet. Genomics 2011, 21:436-439.
66. Garcia-Martin E., Martinez C., Alonso-Navarro H., Benito-Leon J., Puertas I., Rubio L., Lopez-Alburquerque T., Agundez J.A., Jimenez-Jimenez F.J. Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor. Mov. Disord. 2009, 24:1910-1915.
67. Gardiner M., Toth R., Vandermoere F., Morrice N.A., Rouse J. Identification and characterization of FUS/TLS as a new target of ATM. Biochem. J. 2008, 415:297-307.
68. Gehlert D.R. Quantitative autoradiography of Gpp(NH)p sensitive and insensitive [3H]quinpirole binding sites in the rat brain. Synapse 1993, 14:113-120.
69. Goransson M., Wedin M., Aman P. Temperature-dependent localization of TLS-CHOP to splicing factor compartments. Exp. Cell Res. 2002, 278:125-132.
70. Griffon N., Pilon C., Sautel F., Schwartz J.C., Sokoloff P. Two intracellular signaling pathways for the dopamine D3 receptor: opposite and synergistic interactions with cyclic AMP. J. Neurochem. 1997, 68:1-9.
71. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 2001, 411:86-89.
72. Guipaud O., Guillonneau F., Labas V., Praseuth D., Rossier J., Lopez B., Bertrand P. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF(II)68 proteins. Proteomics 2006, 6:5962-5972.
73. Gulcher J.R., Jonsson P., Kong A., Kristjansson K., Frigge M.L., Karason A., Einarsdottir I.E., Stefansson H., Einarsdottir A.S., Sigurthoardottir S., Baldursson S., Bjornsdottir S., Hrafnkelsdottir S.M., Jakobsson F., Benedickz J., Stefansson K. Mapping of a familial essential tremor gene. FET1, to chromosome 3q13. Nat. Genet. 1997, 17:84-87.
74. Hallier M., Lerga A., Barnache S., Tavitian A., Moreau-Gachelin F. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 1998, 273:4838-4842.
75. Handforth A., Homanics G.E., Covey D.F., Krishnan K., Lee J.Y., Sakimura K., Martin F.C., Quesada A. T-type calcium channel antagonists suppress tremor in two mouse models of essential tremor. Neuropharmacology 2010, 59:380-387.
76. Hardenbol P., Baner J., Jain M., Nilsson M., Namsaraev E.A., Karlin-Neumann G.A., Fakhrai-Rad H., Ronaghi M., Willis T.D., Landegren U., Davis R.W. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat. Biotechnol. 2003, 21:673-678.
77. Hartmuth K., Urlaub H., Vornlocher H.P., Will C.L., Gentzel M., Wilm M., Luhrmann R. Protein composition of human prespliceosomes isolated by a tobramycin affinity-selection method. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16719-16724.
78. Hedera P., Davis T.L., Phibbs F.T., Charles P.D., LeDoux M.S. FUS in familial essential tremor - the search for common causes is still on. Parkinsonism Relat. Disord. 2013, 19:818-820.
79. Herndon J.G., Constantinidis I., Moss M.B. Age-related brain changes in rhesus monkeys: a magnetic resonance spectroscopic study. Neuroreport 1998, 9:2127-2130.
80. Heroux M.E., Parisi S.L., Larocerie-Salgado J., Norman K.E. Upper-extremity disability in essential tremor. Arch. Phys. Med. Rehabil. 2006, 87:661-670.
81. Herskovits E., Blackwood W. Essential (familial, hereditary) tremor: a case report. J. Neurol. Neurosurg. Psychiatry 1969, 32:509-511.
82. Hicks G.G., Singh N., Nashabi A., Mai S., Bozek G., Klewes L., Arapovic D., White E.K., Koury M.J., Oltz E.M., Van Kaer L., Ruley H.E. Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nat. Genet. 2000, 24:175-179.
83. Higgins J.J., Lombardi R.Q., Pucilowska J., Jankovic J., Golbe L.I., Verhagen L. HS1-BP3 gene variant is common in familial essential tremor. Mov. Disord. 2006, 21:306-309.
84. Higgins J.J., Lombardi R.Q., Pucilowska J., Jankovic J., Tan E.K., Rooney J.P. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 2005, 64:417-421.
85. Higgins J.J., Loveless J.M., Jankovic J., Patel P.I. Evidence that a gene for essential tremor maps to chromosome 2p in four families. Mov. Disord. 1998, 13:972-977.
86. Higgins J.J., Pho L.T., Nee L.E. A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Mov. Disord. 1997, 12:859-864.
87. Hoffer B.J., Siggins G.R., Oliver A.P., Bloom F.E. Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition. J. Pharmacol. Exp. Ther. 1973, 184:553-569.
88. Huguenard J.R. Low-threshold calcium currents in central nervous system neurons. Annu. Rev. Physiol. 1996, 58:329-348.
89. Ichimura T., Isobe T., Okuyama T., Takahashi N., Araki K., Kuwano R., Takahashi Y. Molecular cloning of cDNA coding for brain-specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:7084-7088.
90. 2+, calmodulin-dependent protein kinase II. FEBS Lett. 1987, 219:79-82.
91. Inashkina I., Radovica I., Smeltere L., Vitols E., Jankevics E. Case-control study of patients with essential tremor in Latvia. Eur. J. Neurol. 2008, 15:988-990.
92. Inoue H., Lin L., Lee X., Shao Z., Mendes S., Snodgrass-Belt P., Sweigard H., Engber T., Pepinsky B., Yang L., Beal M.F., Mi S., Isacson O. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:14430-14435.
93. Ishida K., Mitoma H., Wada Y., Oka T., Shibahara J., Saito Y., Murayama S., Mizusawa H. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 2007, 78:190-192.
94. Ito D., Seki M., Tsunoda Y., Uchiyama H., Suzuki N. Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann. Neurol. 2011, 69:152-162.
95. Iwata S., Nomoto M., Fukuda T. Effects of beta-adrenergic blockers on drug-induced tremors. Pharmacol. Biochem. Behav. 1993, 44:611-613.
96. Jacob C.P., Koutsilieri E., Bartl J., Neuen-Jacob E., Arzberger T., Zander N., Ravid R., Roggendorf W., Riederer P., Grunblatt E. Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. J. Alzheimers Dis. 2007, 11:97-116.
97. Jain S., Lo S.E., Louis E.D. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?. Arch. Neurol. 2006, 63:1100-1104.
98. Jeanneteau F., Funalot B., Jankovic J., Deng H., Lagarde J.P., Lucotte G., Sokoloff P. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10753-10758.
99. Ji B., Li M., Wu W.T., Yick L.W., Lee X., Shao Z., Wang J., So K.F., McCoy J.M., Pepinsky R.B., Mi S., Relton J.K. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol. Cell. Neurosci. 2006, 33:311-320.
100. Jimenez-Jimenez F.J., Alonso-Navarro H., Garcia-Martin E., Agundez J.A. The relationship between Parkinson's disease and essential tremor: review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of Parkinsonism in essential tremor. Tremor Other Hyperkinet. Mov. (N.Y.) 2012, 2.
101. Jimenez-Jimenez F.J., Alonso-Navarro H., Garcia-Martin E., Lorenzo-Betancor O., Pastor P., Agundez J.A. Update on genetics of essential tremor. Acta Neurol. Scand. 2013, 128:359-371.
102. Jimenez-Jimenez F.J., Garcia-Martin E., Lorenzo-Betancor O., Pastor P., Alonso-Navarro H., Agundez J.A. LINGO1 and risk for essential tremor: results of a meta-analysis of rs9652490 and rs11856808. J. Neurol. Sci. 2012, 317:52-57.
103. Jimenez-Jimenez F.J., Rubio L., Alonso-Navarro H., Calleja M., Pilo-de-la-Fuente B., Plaza-Nieto J.F., Benito-Leon J., Garcia-Ruiz P.J., Agundez J.A. Impairment of rapid repetitive finger movements and visual reaction time in patients with essential tremor. Eur. J. Neurol. 2010, 17:152-159.
104. Kaiser R., Hofer A., Grapengiesser A., Gasser T., Kupsch A., Roots I., Brockmoller J. l-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism. Neurology 2003, 60:1750-1755.
105. Keeling B.H., Vilarino-Guell C., Ross O.A., Wszolek Z.K., Uitti R.J., Farrer M.J. DRD3 Ser9Gly and HS1BP3 Ala265Gly are not associated with Parkinson disease. Neurosci. Lett. 2009, 461:74-75.
106. Kim D., Song I., Keum S., Lee T., Jeong M.J., Kim S.S., McEnery M.W., Shin H.S. Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca(2+) channels. Neuron 2001, 31:35-45.
107. Klint P., Hellman U., Wernstedt C., Aman P., Ron D., Claesson-Welsh L. Translocated in liposarcoma (TLS) is a substrate for fibroblast growth factor receptor-1. Cell. Signal. 2004, 16:515-520.
108. Koller W.C., Rubino F.A. Combined resting-postural tremors. Arch. Neurol. 1985, 42:683-684.
109. Kralic J.E., Criswell H.E., Osterman J.L., O'Buckley T.K., Wilkie M.E., Matthews D.B., Hamre K., Breese G.R., Homanics G.E., Morrow A.L. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J. Clin. Invest. 2005, 115:774-779.
110. Kralic J.E., Korpi E.R., O'Buckley T.K., Homanics G.E., Morrow A.L. Molecular and pharmacological characterization of GABA(A) receptor alpha1 subunit knockout mice. J. Pharmacol. Exp. Ther. 2002, 302:1037-1045.
111. Kuhlenbaumer G., Hopfner F., Deuschl G. Genetics of essential tremor: meta-analysis and review. Neurology 2014, 82:1000-1007.
112. Kuo S.H., Tang G., Ma K., Babij R., Cortes E., Vonsattel J.P., Faust P.L., Sulzer D., Louis E.D. Macroautophagy abnormality in essential tremor. PLoS ONE 2012, 7:e53040.
113. Kuroda M., Sok J., Webb L., Baechtold H., Urano F., Yin Y., Chung P., de Rooij D.G., Akhmedov A., Ashley T., Ron D. Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO J. 2000, 19:453-462.
114. Kwiatkowski T.J., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P., de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R., Landers J.E., Brown R.H. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009, 323:1205-1208.
115. Labbe C., Rayaprolu S., Soto-Ortolaza A., Ogaki K., Uitti R.J., Wszolek Z.K., Ross O.A. Investigating FUS variation in Parkinson's disease. Parkinsonism Relat. Disord. 2014, 20(Suppl. 1):S147-S149.
116. Labbe C., Soto-Ortolaza A.I., Rayaprolu S., Harriott A.M., Strongosky A.J., Uitti R.J., Van Gerpen J.A., Wszolek Z.K., Ross O.A. Investigating the role of FUS exonic variants in essential tremor. Parkinsonism Relat. Disord. 2013, 19:755-757.
117. Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: the FUS about TDP-43. Cell 2009, 136:1001-1004.
118. Lagier-Tourenne C., Polymenidou M., Cleveland D.W. TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum. Mol. Genet. 2010, 19:R46-R64.
119. Lance J.W., Schwab R.S., Peterson E.A. Action tremor and the cogwheel phenomenon in Parkinson's disease. Brain 1963, 86:95-110.
120. Landwehrmeyer B., Mengod G., Palacios J.M. Differential visualization of dopamine D2 and D3 receptor sites in rat brain. A comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 1993, 5:145-153.
121. Lannfelt L., Sokoloff P., Martres M.-P., Pilon C., Giros B., Jönsson E., Sedvall G., Schwartz J.-C. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiatr. Genet. 1992, 2:249-256.
122. Lassmann H. Axonal injury in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2003, 74:695-697.
123. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., Butterfield D.A. The glial glutamate transporter GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J. Neurochem. 2001, 78:413-416.
124. Law W.J., Cann K.L., Hicks G.G. TLS, EWS and TAF15: a model for transcriptional integration of gene expression. Brief Funct. Genomics Proteomics 2006, 5:8-14.
125. Lee J.H., Yu W.H., Kumar A., Lee S., Mohan P.S., Peterhoff C.M., Wolfe D.M., Martinez-Vicente M., Massey A.C., Sovak G., Uchiyama Y., Westaway D., Cuervo A.M., Nixon R.A. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 2010, 141:1146-1158.
126. Lee X., Yang Z., Shao Z., Rosenberg S.S., Levesque M., Pepinsky R.B., Qiu M., Miller R.H., Chan J.R., Mi S. NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination. J. Neurosci. 2007, 27:220-225.
127. Lehre K.P., Danbolt N.C. The number of glutamate transporter subtype molecules at glutamatergic synapses: chemical and stereological quantification in young adult rat brain. J. Neurosci. 1998, 18:8751-8757.
128. Lerer B., Segman R.H., Fangerau H., Daly A.K., Basile V.S., Cavallaro R., Aschauer H.N., McCreadie R.G., Ohlraun S., Ferrier N., Masellis M., Verga M., Scharfetter J., Rietschel M., Lovlie R., Levy U.H., Meltzer H.Y., Kennedy J.L., Steen V.M., Macciardi F. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 2002, 27:105-119.
129. Levesque D., Diaz J., Pilon C., Martres M.P., Giros B., Souil E., Schott D., Morgat J.L., Schwartz J.C., Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:8155-8159.
130. Levesque D., Martres M.P., Diaz J., Griffon N., Lammers C.H., Sokoloff P., Schwartz J.C. A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1719-1723.
131. Lill C.M., Schjeide B.M., Graetz C., Ban M., Alcina A., Ortiz M.A., Perez J., Damotte V., Booth D., Lopez de Lapuente A., Broer L., Schilling M., Akkad D.A., Aktas O., Alloza I., Antiguedad A., Arroyo R., Blaschke P., Buttmann M., Chan A., Compston A., Cournu-Rebeix I., Dorner T., Epplen J.T., Fernandez O., Gerdes L.A., Guillot-Noel L., Hartung H.P., Hoffjan S., Izquierdo G., Kemppinen A., Kroner A., Kubisch C., Kumpfel T., Li S.C., Lindenberger U., Lohse P., Lubetzki C., Luessi F., Malhotra S., Mescheriakova J., Montalban X., Papeix C., Paredes L.F., Rieckmann P., Steinhagen-Thiessen E., Winkelmann A., Zettl U.K., Hintzen R., Vandenbroeck K., Stewart G., Fontaine B., Comabella M., Urcelay E., Matesanz F., Sawcer S., Bertram L., Zipp F. MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis. Brain 2013, 136:1778-1782.
132. Lill C.M., Schjeide B.M., Graetz C., Liu T., Damotte V., Akkad D.A., Blaschke P., Gerdes L.A., Kroner A., Luessi F., Cournu-Rebeix I., Hoffjan S., Winkelmann A., Touze E., Pico F., Corcia P., Otaegui D., Antiguedad A., Alcina A., Comabella M., Montalban X., Olascoaga J., Matesanz F., Dorner T., Li S.C., Steinhagen-Thiessen E., Lindenberger U., Chan A., Rieckmann P., Hartung H.P., Aktas O., Lohse P., Buttmann M., Kumpfel T., Kubisch C., Zettl U.K., Epplen J.T., Fontaine B., Zipp F., Vandenbroeck K., Bertram L. Genome-wide significant association of ANKRD55 rs6859219 and multiple sclerosis risk. J. Med. Genet. 2013, 50:140-143.
133. Llinas R., Baker R., Sotelo C. Electrotonic coupling between neurons in cat inferior olive. J. Neurophysiol. 1974, 37:560-571.
134. Llorens F., Gil V., Iraola S., Carim-Todd L., Marti E., Estivill X., Soriano E., del Rio J.A., Sumoy L. Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Dev. Neurobiol. 2008, 68:521-541.
135. Lombardi W.J., Woolston D.J., Roberts J.W., Gross R.E. Cognitive deficits in patients with essential tremor. Neurology 2001, 57:785-790.
136. Lorenz D., Frederiksen H., Moises H., Kopper F., Deuschl G., Christensen K. High concordance for essential tremor in monozygotic twins of old age. Neurology 2004, 62:208-211.
137. Lorenzo-Betancor O., Garcia-Martin E., Cervantes S., Agundez J.A., Jimenez-Jimenez F.J., Alonso-Navarro H., Luengo A., Coria F., Lorenzo E., Irigoyen J., Pastor P. Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. Eur. J. Neurol. 2011, 18:1085-1089.
138. Louis E.D. Etiology of essential tremor: should we be searching for environmental causes?. Mov. Disord. 2001, 16:822-829.
139. Louis E.D. Essential tremor. Lancet Neurol. 2005, 4:100-110.
140. Louis E.D. Functional correlates of lower cognitive test scores in essential tremor. Mov. Disord. 2010, 25:481-485.
141. Louis E.D., Broussolle E., Goetz C.G., Krack P., Kaufmann P., Mazzoni P. Historical underpinnings of the term essential tremor in the late 19th century. Neurology 2008, 71:856-859.
142. Louis E.D., Faust P.L., Vonsattel J.P., Erickson-Davis C. Purkinje cell axonal torpedoes are unrelated to advanced aging and likely reflect cerebellar injury. Acta Neuropathol. 2009, 117:719-721.
143. Louis E.D., Faust P.L., Vonsattel J.P., Honig L.S., Rajput A., Pahwa R., Lyons K.E., Ross W.G., Elble R.J., Erickson-Davis C., Moskowitz C.B., Lawton A. Torpedoes in Parkinson's disease. Alzheimer's disease, essential tremor, and control brains. Mov. Disord. 2009, 24:1600-1605.
144. Louis E.D., Faust P.L., Vonsattel J.P., Honig L.S., Rajput A., Robinson C.A., Pahwa R., Lyons K.E., Ross G.W., Borden S., Moskowitz C.B., Lawton A., Hernandez N. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007, 130:3297-3307.
145. Louis E.D., Ferreira J.J. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov. Disord. 2010, 25:534-541.
146. Louis E.D., Ford B., Frucht S., Ottman R. Mild tremor in relatives of patients with essential tremor: what does this tell us about the penetrance of the disease?. Arch. Neurol. 2001, 58:1584-1589.
147. Louis E.D., Ford B., Lee H., Andrews H., Cameron G. Diagnostic criteria for essential tremor: a population perspective. Arch. Neurol. 1998, 55:823-828.
148. Louis E.D., Kuo S.H., Vonsattel J.P., Faust P.L. Torpedo formation and Purkinje cell loss: modeling their relationship in cerebellar disease. Cerebellum 2014, (Epub ahead of print).
149. Louis E.D., Ottman R. Study of possible factors associated with age of onset in essential tremor. Mov. Disord. 2006, 21:1980-1986.
150. Louis E.D., Ottman R., Ford B., Pullman S., Martinez M., Fahn S., Hauser W.A. The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology 1997, 16:124-133.
151. Louis E.D., Shungu D.C., Chan S., Mao X., Jurewicz E.C., Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci. Lett. 2002, 333:17-20.
152. Lucotte G., Lagarde J.P., Funalot B., Sokoloff P. Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families. Clin. Genet. 2006, 69:437-440.
153. Ma S., Davis T.L., Blair M.A., Fang J.Y., Bradford Y., Haines J.L., Hedera P. Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes?. Mov. Disord. 2006, 21:1368-1374.
154. Malaspina A., Kaushik N., de Belleroche J. A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 2000, 75:2511-2520.
155. Mally J., Baranyi M., Vizi E.S. Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. J. Neural Transm. 1996, 103:555-560.
156. Mann D.M., Stamp J.E., Yates P.O., Bannister C.M. The fine structure of the axonal torpedo in Purkinje cells of the human cerebellum. Neurol. Res. 1980, 1:369-378.
157. Martin F.C., Thu Le A., Handforth A. Harmaline-induced tremor as a potential preclinical screening method for essential tremor medications. Mov. Disord. 2005, 20:298-305.
158. Martinelli P., Rizzo G., Manners D., Tonon C., Pizza F., Testa C., Scaglione C., Barbiroli B., Lodi R. Diffusion-weighted imaging study of patients with essential tremor. Mov. Disord. 2007, 22:1182-1185.
159. Martinez-Vicente M., Talloczy Z., Wong E., Tang G., Koga H., Kaushik S., de Vries R., Arias E., Harris S., Sulzer D., Cuervo A.M. Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 2010, 13:567-576.
160. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 1996, 40:759-766.
161. Mazarei G., Neal S.J., Becanovic K., Luthi-Carter R., Simpson E.M., Leavitt B.R. Expression analysis of novel striatal-enriched genes in Huntington disease. Hum. Mol. Genet. 2010, 19:609-622.
162. McCormick D.A., Bal T. Sleep and arousal: thalamocortical mechanisms. Annu. Rev. Neurosci. 1997, 20:185-215.
163. McGuire V., Van Den Eeden S.K., Tanner C.M., Kamel F., Umbach D.M., Marder K., Mayeux R., Ritz B., Ross G.W., Petrovitch H., Topol B., Popat R.A., Costello S., Manthripragada A.D., Southwick A., Myers R.M., Nelson L.M. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J. Neurol. Sci. 2011, 307:22-29.
164. Meissner M., Lopato S., Gotzmann J., Sauermann G., Barta A. Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins. Exp. Cell Res. 2003, 283:184-195.
165. Merner N.D., Girard S.L., Catoire H., Bourassa C.V., Belzil V.V., Riviere J.B., Hince P., Levert A., Dionne-Laporte A., Spiegelman D., Noreau A., Diab S., Szuto A., Fournier H., Raelson J., Belouchi M., Panisset M., Cossette P., Dupre N., Bernard G., Chouinard S., Dion P.A., Rouleau G.A. Exome sequencing identifies FUS mutations as a cause of essential tremor. Am. J. Hum. Genet. 2012, 91:313-319.
166. Mi S., Hu B., Hahm K., Luo Y., Kam Hui E.S., Yuan Q., Wong W.M., Wang L., Su H., Chu T.H., Guo J., Zhang W., So K.F., Pepinsky B., Shao Z., Graff C., Garber E., Jung V., Wu E.X., Wu W. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat. Med. 2007, 13:1228-1233.
167. Mi S., Lee X., Shao Z., Thill G., Ji B., Relton J., Levesque M., Allaire N., Perrin S., Sands B., Crowell T., Cate R.L., McCoy J.M., Pepinsky R.B. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 2004, 7:221-228.
168. Mi S., Miller R.H., Lee X., Scott M.L., Shulag-Morskaya S., Shao Z., Chang J., Thill G., Levesque M., Zhang M., Hession C., Sah D., Trapp B., He Z., Jung V., McCoy J.M., Pepinsky R.B. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat. Neurosci. 2005, 8:745-751.
169. Mi S., Sandrock A., Miller R.H. LINGO-1 and its role in CNS repair. Int. J. Biochem. Cell Biol. 2008, 40:1971-1978.
170. Milner T.E., Cadoret G., Lessard L., Smith A.M. EMG analysis of harmaline-induced tremor in normal and three strains of mutant mice with Purkinje cell degeneration and the role of the inferior olive. J. Neurophysiol. 1995, 73:2568-2577.
171. Mitani A., Tanaka K. Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 2003, 23:7176-7182.
172. Miwa H. Rodent models of tremor. Cerebellum 2007, 6:66-72.
173. Moises H.C., Waterhouse B.D., Woodward D.J. Locus coeruleus stimulation potentiates Purkinje cell responses to afferent input: the climbing fiber system. Brain Res. 1981, 222:43-64.
174. Moises H.C., Woodward D.J. Potentiation of GABA inhibitory action in cerebrllum by locus coeruleus stimulation. Brain Res. 1980, 182:327-344.
175. Montgomery E.B., Baker K.B., Lyons K., Koller W.C. Motor initiation and execution in essential tremor and Parkinson's disease. Mov. Disord. 2000, 15:511-515.
176. Mookherjee P., Green P.S., Watson G.S., Marques M.A., Tanaka K., Meeker K.D., Meabon J.S., Li N., Zhu P., Olson V.G., Cook D.G. GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model. J. Alzheimers Dis. 2011, 26:447-455.
177. Murakami T., Yang S.P., Xie L., Kawano T., Fu D., Mukai A., Bohm C., Chen F., Robertson J., Suzuki H., Tartaglia G.G., Vendruscolo M., Kaminski Schierle G.S., Chan F.T., Moloney A., Crowther D., Kaminski C.F., Zhen M., St George-Hyslop P. ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism. Hum. Mol. Genet. 2012, 21:1-9.
178. Nahab F.B., Handforth A., Brown T., Shin C., Quesada A., Dong C., Haubenberger D., Hallett M. Octanoic acid suppresses harmaline-induced tremor in mouse model of essential tremor. Neurotherapeutics 2012, 9:635-638.
179. Narendra D.P., Jin S.M., Tanaka A., Suen D.F., Gautier C.A., Shen J., Cookson M.R., Youle R.J. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 2010, 8:e1000298.
180. Ng L., Bernard A., Lau C., Overly C.C., Dong H.W., Kuan C., Pathak S., Sunkin S.M., Dang C., Bohland J.W., Bokil H., Mitra P.P., Puelles L., Hohmann J., Anderson D.J., Lein E.S., Jones A.R., Hawrylycz M. An anatomic gene expression atlas of the adult mouse brain. Nat. Neurosci. 2009, 12:356-362.
181. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M., Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., Shendure J., Bamshad M.J. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
182. Nomura T., Inoue Y., Kusumi M., Uemura Y., Nakashima K. Prevalence of restless legs syndrome in a rural community in Japan. Mov. Disord. 2008, 23:2363-2369.
183. O'Hearn E., Molliver M.E. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 1993, 55:303-310.
184. O'Hearn E., Molliver M.E. Administration of a non-NMDA antagonist GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine. Neuroscience 2004, 127:373-383.
185. O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B., Phelps I.G., Carvill G., Kumar A., Lee C., Ankenman K., Munson J., Hiatt J.B., Turner E.H., Levy R., O'Day D.R., Krumm N., Coe B.P., Martin B.K., Borenstein E., Nickerson D.A., Mefford H.C., Doherty D., Akey J.M., Bernier R., Eichler E.E., Shendure J. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
186. Ortega-Cubero S., Lorenzo-Betancor O., Lorenzo E., Alonso E., Coria F., Pastor M.A., Fernandez-Santiago R., Marti M.J., Ezquerra M., Valldeoriola F., Compta Y., Tolosa E., Agundez J.A., Jimenez-Jimenez F.J., Gironell A., Clarimon J., de Castro P., Garcia-Martin E., Alonso-Navarro H., Pastor P. Fused in sarcoma (FUS) gene mutations are not a frequent cause of essential tremor in Europeans. Neurobiol. Aging 2013, 34:2441.e9-2441.e11.
187. Ostroff L.E., Fiala J.C., Allwardt B., Harris K.M. Polyribosomes redistribute from dendritic shafts into spines with enlarged synapses during LTP in developing rat hippocampal slices. Neuron 2002, 35:535-545.
188. Ozekmekci S., Kiziltan G., Vural M., Ertan S., Apaydin H., Erginoz E. Assessment of movement time in patients with essential tremor. J. Neurol. 2005, 252:964-967.
189. Pagan F.L., Butman J.A., Dambrosia J.M., Hallett M. Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology 2003, 60:1344-1347.
190. Papadopoulos D., Pham-Dinh D., Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp. Neurol. 2006, 197:373-385.
191. Paris-Robidas S., Brochu E., Sintes M., Emond V., Bousquet M., Vandal M., Pilote M., Tremblay C., Di Paolo T., Rajput A.H., Rajput A., Calon F. Defective dentate nucleus GABA receptors in essential tremor. Brain 2012, 135:105-116.
192. Park Y.G., Park H.Y., Lee C.J., Choi S., Jo S., Choi H., Kim Y.H., Shin H.S., Llinas R.R., Kim D. Ca(V)3.1 is a tremor rhythm pacemaker in the inferior olive. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10731-10736.
193. Parmalee N., Mirzozoda K., Kisselev S., Merner N., Dion P., Rouleau G., Clark L., Louis E.D. Genetic analysis of the FUS/TLS gene in essential tremor. Eur. J. Neurol. 2013, 20:534-539.
194. Patsopoulos N.A., Esposito F., Reischl J., Lehr S., Bauer D., Heubach J., Sandbrink R., Pohl C., Edan G., Kappos L., Miller D., Montalban J., Polman C.H., Freedman M.S., Hartung H.P., Arnason B.G., Comi G., Cook S., Filippi M., Goodin D.S., Jeffery D., O'Connor P., Ebers G.C., Langdon D., Reder A.T., Traboulsee A., Zipp F., Schimrigk S., Hillert J., Bahlo M., Booth D.R., Broadley S., Brown M.A., Browning B.L., Browning S.R., Butzkueven H., Carroll W.M., Chapman C., Foote S.J., Griffiths L., Kermode A.G., Kilpatrick T.J., Lechner-Scott J., Marriott M., Mason D., Moscato P., Heard R.N., Pender M.P., Perreau V.M., Perera D., Rubio J.P., Scott R.J., Slee M., Stankovich J., Stewart G.J., Taylor B.V., Tubridy N., Willoughby E., Wiley J., Matthews P., Boneschi F.M., Compston A., Haines J., Hauser S.L., McCauley J., Ivinson A., Oksenberg J.R., Pericak-Vance M., Sawcer S.J., De Jager P.L., Hafler D.A., de Bakker P.I. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 2011, 70:897-912.
195. Paus S., Gadow F., Kaut O., Knapp M., Klein C., Klockgether T., Wullner U. Tremor in Parkinson's disease is not associated with the DRD3 Ser9Gly polymorphism. Parkinsonism Relat. Disord. 2010, 16:381-383.
196. Paus S., Gadow F., Knapp M., Klein C., Klockgether T., Wullner U. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism. Mov. Disord. 2009, 24:1080-1084.
197. Powers C.A., Mathur M., Raaka B.M., Ron D., Samuels H.H. TLS (translocated-in-liposarcoma) is a high-affinity interactor for steroid, thyroid hormone, and retinoid receptors. Mol. Endocrinol. 1998, 12:4-18.
198. Quattrone A., Cerasa A., Messina D., Nicoletti G., Hagberg G.E., Lemieux L., Novellino F., Lanza P., Arabia G., Salsone M. Essential head tremor is associated with cerebellar vermis atrophy: a volumetric and voxel-based morphometry MR imaging study. Am. J. Neuroradiol. 2008, 29:1692-1697.
199. Quesada A., Bui P.H., Homanics G.E., Hankinson O., Handforth A. Comparison of mibefradil and derivative NNC 55-0396 effects on behavior, cytochrome P450 activity, and tremor in mouse models of essential tremor. Eur. J. Pharmacol. 2011, 659:30-36.
200. Rajput A., Rajput A.H., Rajput M.L., Encarnacion M., Bernales C.Q., Ross J.P., Farrer M.J., Vilarino-Guell C. Identification of FUS p.R377W in essential tremor. Eur. J. Neurol. 2014, 21:361-363.
201. Rajput A.H., Adler C.H., Shill H.A., Rajput A. Essential tremor is not a neurodegenerative disease. Neurodegener. Dis. Manage. 2012, 2:259-268.
202. Rajput A.H., Rozdilsky B., Ang L., Rajput A. Clinicopathologic observations in essential tremor: report of six cases. Neurology 1991, 41:1422-1424.
203. Rapp T.B., Yang L., Conrad E.U., Mandahl N., Chansky H.A. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells. J. Orthop. Res. 2002, 20:723-729.
204. Rappsilber J., Friesen W.J., Paushkin S., Dreyfuss G., Mann M. Detection of arginine dimethylated peptides by parallel precursor ion scanning mass spectrometry in positive ion mode. Anal. Chem. 2003, 75:3107-3114.
205. Rappsilber J., Ryder U., Lamond A.I., Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res. 2002, 12:1231-1245.
206. Ross J.P., Rayaprolu S., Bernales C.Q., Soto-Ortolaza A.I., van Gerpen J., Uitti R.J., Wszolek Z.K., Rajput A., Rajput A.H., Rajput M.L., Ross O.A., Vilarino-Guell C. SLC1A2 rs3794087 does not associate with essential tremor. Neurobiol. Aging 2014, 35:935.e9-935.e10.
207. Sawcer S., Hellenthal G., Pirinen M., Spencer C.C., Patsopoulos N.A., Moutsianas L., Dilthey A., Su Z., Freeman C., Hunt S.E., Edkins S., Gray E., Booth D.R., Potter S.C., Goris A., Band G., Oturai A.B., Strange A., Saarela J., Bellenguez C., Fontaine B., Gillman M., Hemmer B., Gwilliam R., Zipp F., Jayakumar A., Martin R., Leslie S., Hawkins S., Giannoulatou E., D'Alfonso S., Blackburn H., Martinelli Boneschi F., Liddle J., Harbo H.F., Perez M.L., Spurkland A., Waller M.J., Mycko M.P., Ricketts M., Comabella M., Hammond N., Kockum I., McCann O.T., Ban M., Whittaker P., Kemppinen A., Weston P., Hawkins C., Widaa S., Zajicek J., Dronov S., Robertson N., Bumpstead S.J., Barcellos L.F., Ravindrarajah R., Abraham R., Alfredsson L., Ardlie K., Aubin C., Baker A., Baker K., Baranzini S.E., Bergamaschi L., Bergamaschi R., Bernstein A., Berthele A., Boggild M., Bradfield J.P., Brassat D., Broadley S.A., Buck D., Butzkueven H., Capra R., Carroll W.M., Cavalla P., Celius E.G., Cepok S., Chiavacci R., Clerget-Darpoux F., Clysters K., Comi G., Cossburn M., Cournu-Rebeix I., Cox M.B., Cozen W., Cree B.A., Cross A.H., Cusi D., Daly M.J., Davis E., de Bakker P.I., Debouverie M., D'Hooghe M.B., Dixon K., Dobosi R., Dubois B., Ellinghaus D., Elovaara I., Esposito F., Fontenille C., Foote S., Franke A., Galimberti D., Ghezzi A., Glessner J., Gomez R., Gout O., Graham C., Grant S.F., Guerini F.R., Hakonarson H., Hall P., Hamsten A., Hartung H.P., Heard R.N., Heath S., Hobart J., Hoshi M., Infante-Duarte C., Ingram G., Ingram W., Islam T., Jagodic M., Kabesch M., Kermode A.G., Kilpatrick T.J., Kim C., Klopp N., Koivisto K., Larsson M., Lathrop M., Lechner-Scott J.S., Leone M.A., Leppa V., Liljedahl U., Bomfim I.L., Lincoln R.R., Link J., Liu J., Lorentzen A.R., Lupoli S., Macciardi F., Mack T., Marriott M., Martinelli V., Mason D., McCauley J.L., Mentch F., Mero I.L., Mihalova T., Montalban X., Mottershead J., Myhr K.M., Naldi P., Ollier W., Page A., Palotie A., Pelletier J., Piccio L., Pickersgill T., Piehl F., Pobywajlo S., Quach H.L., Ramsay P.P., Reunanen M., Reynolds R., Rioux J.D., Rodegher M., Roesner S., Rubio J.P., Ruckert I.M., Salvetti M., Salvi E., Santaniello A., Schaefer C.A., Schreiber S., Schulze C., Scott R.J., Sellebjerg F., Selmaj K.W., Sexton D., Shen L., Simms-Acuna B., Skidmore S., Sleiman P.M., Smestad C., Sorensen P.S., Sondergaard H.B., Stankovich J., Strange R.C., Sulonen A.M., Sundqvist E., Syvanen A.C., Taddeo F., Taylor B., Blackwell J.M., Tienari P., Bramon E., Tourbah A., Brown M.A., Tronczynska E., Casas J.P., Tubridy N., Corvin A., Vickery J., Jankowski J., Villoslada P., Markus H.S., Wang K., Mathew C.G., Wason J., Palmer C.N., Wichmann H.E., Plomin R., Willoughby E., Rautanen A., Winkelmann J., Wittig M., Trembath R.C., Yaouanq J., Viswanathan A.C., Zhang H., Wood N.W., Zuvich R., Deloukas P., Langford C., Duncanson A., Oksenberg J.R., Pericak-Vance M.A., Haines J.L., Olsson T., Hillert J., Ivinson A.J., De Jager P.L., Peltonen L., Stewart G.J., Hafler D.A., Hauser S.L., McVean G., Donnelly P., Compston A. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011, 476:214-219.
208. Schmouth J.F., Bonaguro R.J., Corso-Diaz X., Simpson E.M. Modelling human regulatory variation in mouse: finding the function in genome-wide association studies and whole-genome sequencing. PLoS Genet. 2012, 8:e1002544.
209. Schrag A., Munchau A., Bhatia K.P., Quinn N.P., Marsden C.D. Essential tremor: an overdiagnosed condition?. J. Neurol. 2000, 247:955-959.
210. Schuman E.M., Dynes J.L., Steward O. Synaptic regulation of translation of dendritic mRNAs. J. Neurosci. 2006, 26:7143-7146.
211. Scott H.A., Gebhardt F.M., Mitrovic A.D., Vandenberg R.J., Dodd P.R. Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease. Neurobiol. Aging 2011, 32(553):e511-e551.
212. Seal R.P., Amara S.G. Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 1999, 39:431-456.
213. Shatunov A., Jankovic J., Elble R., Sambuughin N., Singleton A., Hallett M., Goldfarb L. A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 2005, 65. (author reply 1995).
214. Shi T., Xie J., Xiong Y., Deng W., Guo J., Wang F., Ma D. Human HS1BP3 induces cell apoptosis and activates AP-1. BMB Rep. 2011, 44:381-386.
215. Shin D.H., Han B.S., Kim H.S., Lee P.H. Diffusion tensor imaging in patients with essential tremor. Am. J. Neuroradiol. 2008, 29:151-153.
216. Simantov R., Snyder S.H., Oster-Granite M.L. Harmaline-induced tremor in the rat: abolition by 3-acetylpyridine destruction of cerebellar climbing fibers. Brain Res. 1976, 114:144-151.
217. Skarnes W.C., Rosen B., West A.P., Koutsourakis M., Bushell W., Iyer V., Mujica A.O., Thomas M., Harrow J., Cox T., Jackson D., Severin J., Biggs P., Fu J., Nefedov M., de Jong P.J., Stewart A.F., Bradley A. A conditional knockout resource for the genome-wide study of mouse gene function. Nature 2011, 474:337-342.
218. Sokoloff P., Giros B., Martres M.P., Bouthenet M.L., Schwartz J.C. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990, 347:146-151.
219. Spencer B., Potkar R., Trejo M., Rockenstein E., Patrick C., Gindi R., Adame A., Wyss-Coray T., Masliah E. Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J. Neurosci. 2009, 29:13578-13588.
220. Stefansson H., Steinberg S., Petursson H., Gustafsson O., Gudjonsdottir I.H., Jonsdottir G.A., Palsson S.T., Jonsson T., Saemundsdottir J., Bjornsdottir G., Bottcher Y., Thorlacius T., Haubenberger D., Zimprich A., Auff E., Hotzy C., Testa C.M., Miyatake L.A., Rosen A.R., Kristleifsson K., Rye D., Asmus F., Schols L., Dichgans M., Jakobsson F., Benedikz J., Thorsteinsdottir U., Gulcher J., Kong A., Stefansson K. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat. Genet. 2009, 41:277-279.
221. Stergachis A.B., Haugen E., Shafer A., Fu W., Vernot B., Reynolds A., Raubitschek A., Ziegler S., LeProust E.M., Akey J.M., Stamatoyannopoulos J.A. Exonic transcription factor binding directs codon choice and affects protein evolution. Science 2013, 342:1367-1372.
222. Stohr T., Lekieffre D., Freitag J. Lacosamide, the new anticonvulsant, effectively reduces harmaline-induced tremors in rats. Eur. J. Pharmacol. 2008, 589:114-116.
223. Sugihara I., Lang E.J., Llinas R. Serotonin modulation of inferior olivary oscillations and synchronicity: a multiple-electrode study in the rat cerebellum. Eur. J. Neurosci. 1995, 7:521-534.
224. Sullivan K.L., Hauser R.A., Zesiewicz T.A. Essential tremor epidemiology, diagnosis, and treatment. Neurologist 2004, 10:250-258.
225. Sur C., Wafford K.A., Reynolds D.S., Hadingham K.L., Bromidge F., Macaulay A., Collinson N., O'Meara G., Howell O., Newman R., Myers J., Atack J.R., Dawson G.R., McKernan R.M., Whiting P.J., Rosahl T.W. Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice. J. Neurosci. 2001, 21:3409-3418.
226. Symanski C., Shill H.A., Dugger B., Hentz J.G., Adler C.H., Jacobson S.A., Driver-Dunckley E., Beach T.G. Essential tremor is not associated with cerebellar Purkinje cell loss. Mov. Disord. 2014, 29:496-500.
227. Takahashi M., Kovalchuk Y., Attwell D. Pre- and postsynaptic determinants of EPSC waveform at cerebellar climbing fiber and parallel fiber to Purkinje cell synapses. J. Neurosci. 1995, 15:5693-5702.
228. Takahashi N., Iwatsubo T., Nakano I., Machinami R. Focal appearance of cerebellar torpedoes associated with discrete lesions in the cerebellar white matter. Acta Neuropathol. 1992, 84:153-156.
229. Takarada T., Tamaki K., Takumi T., Ogura M., Ito Y., Nakamichi N., Yoneda Y. A protein-protein interaction of stress-responsive myosin VI endowed to inhibit neural progenitor self-replication with RNA binding protein. TLS, in murine hippocampus. J. Neurochem. 2009, 110:1457-1468.
230. Takayama C. Formation of GABAergic synapses in the cerebellum. Cerebellum 2005, 4:171-177.
231. Takayasu Y., Iino M., Ozawa S. Roles of glutamate transporters in shaping excitatory synaptic currents in cerebellar Purkinje cells. Eur. J. Neurosci. 2004, 19:1285-1295.
232. Takemoto Y., Furuta M., Sato M., Kubo M., Hashimoto Y. Isolation and characterization of a novel HS1 SH3 domain binding protein. HS1BP3. Int. Immunol. 1999, 11:1957-1964.
233. Talley E.M., Cribbs L.L., Lee J.H., Daud A., Perez-Reyes E., Bayliss D.A. Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J. Neurosci. 1999, 19:1895-1911.
234. Tan A.Y., Manley J.L. The TET family of proteins: functions and roles in disease. J. Mol. Cell Biol. 2009, 1:82-92.
235. Tan E.K., Foo J.N., Tan L., Au W.L., Prakash K.M., Ng E., Ikram M.K., Wong T.Y., Liu J.J., Zhao Y. SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects. Neurology 2013, 80:1618-1619.
236. Tan E.K., Prakash K.M., Fook-Chong S., Yih Y., Chua E., Lum S.Y., Wong M.C., Pavanni R., Zhao Y. DRD3 variant and risk of essential tremor. Neurology 2007, 68:790-791.
237. Tan E.K., Teo Y.Y., Prakash K.M., Li R., Lim H.Q., Angeles D., Tan L.C., Au W.L., Yih Y., Zhao Y. LINGO1 variant increases risk of familial essential tremor. Neurology 2009, 73:1161-1162.
238. Tanaka K. Functions of glutamate transporters in the brain. Neurosci. Res. 2000, 37:15-19.
239. Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997, 276:1699-1702.
240. Tanner C.M., Goldman S.M., Lyons K.E., Aston D.A., Tetrud J.W., Welsh M.D., Langston J.W., Koller W.C. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 2001, 57:1389-1391.
241. Tedeschi G., Bertolino A., Campbell G., Barnett A.S., Duyn J.H., Jacob P.K., Moonen C.T., Alger J.R., Di Chiro G. Reproducibility of proton MR spectroscopic imaging findings. Am. J. Neuroradiol. 1996, 17:1871-1879.
242. Thier S., Kuhlenbaumer G., Lorenz D., Nothnagel M., Nebel A., Christensen K., Schreiber S., Deuschl G., Klebe S. GABA(A) receptor- and GABA transporter polymorphisms and risk for essential tremor. Eur. J. Neurol. 2011, 18:1098-1100.
243. Thier S., Lorenz D., Nothnagel M., Poremba C., Papengut F., Appenzeller S., Paschen S., Hofschulte F., Hussl A.C., Hering S., Poewe W., Asmus F., Gasser T., Schols L., Christensen K., Nebel A., Schreiber S., Klebe S., Deuschl G., Kuhlenbaumer G. Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology 2012, 79:243-248.
244. Thier S., Lorenz D., Nothnagel M., Stevanin G., Durr A., Nebel A., Schreiber S., Kuhlenbaumer G., Deuschl G., Klebe S. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov. Disord. 2010, 25:717-723.
245. Ticozzi N., Silani V., LeClerc A.L., Keagle P., Gellera C., Ratti A., Taroni F., Kwiatkowski T.J., McKenna-Yasek D.M., Sapp P.C., Brown R.H., Landers J.E. Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort. Neurology 2009, 73:1180-1185.
246. Tison F., Crochard A., Leger D., Bouee S., Lainey E., El Hasnaoui A. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT study. Neurology 2005, 65:239-246.
247. Toyooka K., Muratake T., Tanaka T., Igarashi S., Watanabe H., Takeuchi H., Hayashi S., Maeda M., Takahashi M., Tsuji S., Kumanishi T., Takahashi Y. 14-3-3 protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia. Am. J. Med. Genet. 1999, 88:164-167.
248. Tsukada S., Iino M., Takayasu Y., Shimamoto K., Ozawa S. Effects of a novel glutamate transporter blocker. (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), on activities of hippocampal neurons. Neuropharmacology 2005, 48:479-491.
249. Uranishi H., Tetsuka T., Yamashita M., Asamitsu K., Shimizu M., Itoh M., Okamoto T. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol. Chem. 2001, 276:13395-13401.
250. Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M., Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 2010, 74:366-371.
251. Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N., Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C., Shaw C.E. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211.
252. Verschuuren J., Chuang L., Rosenblum M.K., Lieberman F., Pryor A., Posner J.B., Dalmau J. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol. 1996, 91:519-525.
253. Vicini S., Ferguson C., Prybylowski K., Kralic J., Morrow A.L., Homanics G.E. GABA(A) receptor alpha1 subunit deletion prevents developmental changes of inhibitory synaptic currents in cerebellar neurons. J. Neurosci. 2001, 21:3009-3016.
254. Vilarino-Guell C., Ross O.A., Wider C., Jasinska-Myga B., Cobb S.A., Soto-Ortolaza A.I., Kachergus J.M., Keeling B.H., Dachsel J.C., Melrose H.L., Behrouz B., Wszolek Z.K., Uitti R.J., Aasly J.O., Rajput A., Farrer M.J. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat. Disord. 2010, 16:109-111.
255. Vilarino-Guell C., Wider C., Ross O.A., Jasinska-Myga B., Kachergus J., Cobb S.A., Soto-Ortolaza A.I., Behrouz B., Heckman M.G., Diehl N.N., Testa C.M., Wszolek Z.K., Uitti R.J., Jankovic J., Louis E.D., Clark L.N., Rajput A., Farrer M.J. LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 2010, 11:401-408.
256. Vion-Dury J., Nicoli F., Salvan A.M., Confort-Gouny S., Dhiver C., Cozzone P.J. Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 1995, 345:60-61.
257. Vitale C., Gulli R., Ciotti P., Scaglione C., Bellone E., Avanzino L., Lantieri F., Abbruzzese G., Martinelli P., Barone P., Mandich P. DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. Eur. J. Neurol. 2008, 15:985-987.
258. Waibel S., Neumann M., Rabe M., Meyer T., Ludolph A.C. Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology 2010, 75:815-817.
259. Wang G.J., Yang P., Xie H.G. Gene variants in noncoding regions and their possible consequences. Pharmacogenomics 2006, 7:203-209.
260. Wang J., Liu Z.L., Chen B. Association study of dopamine D2. D3 receptor gene polymorphisms with motor fluctuations in PD. Neurology 2001, 56:1757-1759.
261. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M.G., Glass C.K., Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008, 454:126-130.
262. Watanabe M., Isobe T., Ichimura T., Kuwano R., Takahashi Y., Kondo H. Developmental regulation of neuronal expression for the eta subtype of the 14-3-3 protein, a putative regulatory protein for protein kinase C. Brain Res. Dev. Brain Res. 1993, 73:225-235.
263. Wills A.J., Jenkins I.H., Thompson P.D., Findley L.J., Brooks D.J. Red nuclear and cerebellar but no olivary activation associated with essential tremor: a positron emission tomographic study. Ann. Neurol. 1994, 36:636-642.
264. Wilms H., Sievers J., Deuschl G. Animal models of tremor. Mov. Disord. 1999, 14:557-571.
265. Woltjer R.L., Duerson K., Fullmer J.M., Mookherjee P., Ryan A.M., Montine T.J., Kaye J.A., Quinn J.F., Silbert L., Erten-Lyons D., Leverenz J.B., Bird T.D., Pow D.V., Tanaka K., Watson G.S., Cook D.G. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2010, 69:667-676.
266. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat. Neurosci. 2010, 13:805-811.
267. Wu Y.R., Foo J.N., Tan L.C., Chen C.M., Prakash K.M., Chen Y.C., Bei J.X., Au W.L., Chang C.W., Wong T.Y., Liu J.J., Zhao Y., Tan E.K. Identification of a novel risk variant in the FUS gene in essential tremor. Neurology 2013, 81:541-544.
268. Wu Y.W., Rong T.Y., Li H.H., Xiao Q., Fei Q.Z., Tan E.K., Ding J.Q., Chen S.D. Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta Neurol. Scand. 2011, 124:264-268.
269. Yang L., Embree L.J., Hickstein D.D. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 2000, 20:3345-3354.
270. Yoshimura A., Fujii R., Watanabe Y., Okabe S., Fukui K., Takumi T. Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines. Curr. Biol. 2006, 16:2345-2351.
271. Young K.A., Berry M.L., Mahaffey C.L., Saionz J.R., Hawes N.L., Chang B., Zheng Q.Y., Smith R.S., Bronson R.T., Nelson R.J., Simpson E.M. Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent. Behav. Brain Res. 2002, 132:145-158.
272. Yu S.W., Chen C.M., Chen Y.C., Chang C.W., Chang H.S., Lyu R.K., Ro L.S., Wu Y.R. SLC1A2 variant is associated with essential tremor in Taiwanese population. PLoS ONE 2013, 8:e71919.
273. Zesiewicz T.A., Elble R., Louis E.D., Hauser R.A., Sullivan K.L., Dewey R.B., Ondo W.G., Gronseth G.S., Weiner W.J. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005, 64:2008-2020.
274. Zhao X.H., Jin W.L., Wu J., Mi S., Ju G. Inactivation of glycogen synthase kinase-3beta and up-regulation of LINGO-1 are involved in LINGO-1 antagonist regulated survival of cerebellar granular neurons. Cell. Mol. Neurobiol. 2008, 28:727-735.
275. Zheng W., Deng X., Liang H., Song Z., Gao K., Yang Y., Deng H. Genetic analysis of the fused in sarcoma gene in Chinese Han patients with essential tremor. Neurobiol. Aging 2013, 34:2078.e3-2078.e4.
276. Zhou Z., Licklider L.J., Gygi S.P., Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 2002, 419:182-185.
277. Zhou Z.D., Sathiyamoorthy S., Tan E.K. LINGO-1 and neurodegeneration: pathophysiologic clues for essential tremor. Tremor Other Hyperkinet. Mov. (N.Y.) 2012, 2.
278. Zinszner H., Albalat R., Ron D. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev. 1994, 8:2513-2526.
279. Zinszner H., Immanuel D., Yin Y., Liang F.X., Ron D. A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 1997, 14:451-461.
280. Zinszner H., Sok J., Immanuel D., Yin Y., Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J. Cell Sci. 1997, 110(Pt 15):1741-1750.
281. Zuo X., Jiang H., Guo J.F., Yu R.H., Sun Q.Y., Hu L., Wang L., Yao L.Y., Shen L., Pan Q., Yan X.X., Xia K., Tang B.S. Screening for two SNPs of LINGO1 gene in patients with essential tremor or sporadic Parkinson's disease in Chinese population. Neurosci. Lett. 2010, 481:69-72.